Oropharyngeal squamous cell carcinoma (opscc)
Clinical trials for Oropharyngeal squamous cell carcinoma (opscc) explained in plain language.
Never miss a new study
Get alerted when new Oropharyngeal squamous cell carcinoma (opscc) trials appear
Sign up with your email to follow new studies for Oropharyngeal squamous cell carcinoma (opscc), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a migraine drug make oral cancer treatment hit harder?
Disease control Not yet recruitingResearchers are testing whether adding rimegepant to standard chemoimmunotherapy before surgery helps shrink oral or oropharyngeal squamous cell carcinoma more effectively. The trial enrolls adults with primary or recurrent disease who are scheduled for surgery. Participants rece…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA (OPSCC)
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
MRI scans may reveal which throat cancer patients need stronger treatment
Diagnosis Not yet recruitingThis study tests whether special MRI scans can predict how well HPV-positive throat cancer responds to standard chemotherapy and radiation. Researchers will scan 30 adults before treatment and track their outcomes. The goal is to see if MRI patterns can identify low-risk patients…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA (OPSCC)
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Symptom relief Not yet recruitingThis study is for people with HPV-related oropharyngeal (throat) cancer, which often responds well to treatment. The goal is to see if lowering the radiation dose to certain areas can reduce side effects like dry mouth without hurting the chance of curing the cancer. About 132 pa…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA (OPSCC)
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC